期刊文献+

骨肽注射液治疗骨质疏松症60例临床分析 被引量:11

下载PDF
导出
摘要 目的探讨骨肽注射液治疗骨质疏松症的临床效果。方法将收治的60例骨质疏松症患者,随机分为对照组和观察组,对照组采用口服葡萄糖酸钙片及理疗治疗,观察组在对照组的基础上加用骨肽注射液治疗。分析两组治疗效果及不良反应发生情况。结果对照组总有效率36.7%,观察组总有效率70%。两组总有效率经统计学分析,差异有统计学意义(P<0.05)。观察组与对照组治疗前腰椎、髋部骨密度经统计学分析,差异无统计学意义。观察组治疗后腰椎、髋部骨密度显著高于对照组,差异有统计学意义(P<0.05)。结论采用骨肽注射液联合钙剂治疗,疗效优于单用钙剂治疗。治疗后患者骨质疏松症状显著改善,骨密度有不同程度增高,使用方便,不良反应少,值得临床推广应用。
作者 田杰
出处 《当代医学》 2012年第11期151-151,共1页 Contemporary Medicine
  • 相关文献

参考文献5

二级参考文献26

  • 1李景田,邹锦慧,张慧明,李伯灵,何文英,周小璜,李沐吉.序贯应用甲状旁腺素和二膦酸盐预防激素性骨质疏松的实验研究[J].广东医学,2006,27(4):473-475. 被引量:5
  • 2[1]Kung AW,Yeung SS,Chu LW.The efficacy and tolerability of alendronate in postmenopausal osteoporotic chinese women:a randomized placebo-controlled study[J].Calcif Tissue Int,2000,67(2):286-290.
  • 3[2]Arai H,Miyamoto KI,Yoshida M,et al.The polymorphism in the candal-related homeodomain protein Cdx-2 binding element in the human witamin D receptor gene[J].J Bone Miner Res,2001,16(9):1256-1264.
  • 4[3]Li YC,Bolt MJ,Cao LP,et al.Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism[J].Am J Physiol Endocrinol Metab,2001,281(suppl):558-564.
  • 5[4]Kadiyala S,Nagaba S,Takeuchi K,et al.Metabolites and analogs of lalpha,25*.dihydroxyvitaminD(3):evaluation of actions in bone[J].Steroids,2001,66(2):347-355.
  • 6[5]Reginster J,Minne HW,Sorensen OH,et al.Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis.Vertebral efficacy with risedronate therapy (VERT) study group[J].Osteoporos Int,2000,11(1):83-91.
  • 7[6]Paul W,Phuong N,Cathleen V,et al.The estrogen receptor enhances AP*.1 activity by two distinct mechanisms with different requirement for receptor transativation functions[J].Mol Endocrinol,1999,139(10):1672-1685.
  • 8[7]Mitlak BH,Cohen FJ.Selective estrogen receptor modulators:A look ahead[J].Drugs,1999,57(4):653-663.
  • 9[8]Hua ZK,Hong QD.Lasofoxifen (CP*.336 156) a selective estrogen receptor modulator,prevents bone loss induced by aging and orchidectomy in the adult rat[J].Endocrinology,2000,141(9):1338-1344.
  • 10[9]Evdokiou A,Raggatt LJ,Sakai T,et al.Identification of a novel calcitonin-response element in the promoter of the human P21 WAFI/CIP1 gene[J].J Mol Endocrinol,2000,25(1):195-206.

共引文献45

同被引文献130

引证文献11

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部